USA |OTCQB |USD
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||49.96%||Ex-Dividend Date|
|Held by Institutions||-||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Sep 21||Jun 21||Mar 21|
Acro biomedical co., ltd trades on the OTC Markets stock market in USA under the ticker symbol "ACBM". Acro biomedical co., ltd’s stock symbol can also be displayed as "OTCMKTS:ACBM".
Acro biomedical co., ltd (OTCMKTS:ACBM) is owned by 0.00% institutional shareholders and by 49.96% insiders. The rest is owned by the public.
Explore More Details on Acro biomedical co., ltd's “Ownership” Section
Acro biomedical co., ltd's key executive team includes the following managers:
Acro biomedical co., ltd (OTCMKTS:ACBM) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Acro biomedical co., ltd is 0.
Acro biomedical co., ltd (OTCMKTS:ACBM) is headquartered in IN, United States.
Acro biomedical co., ltd’s mailing address is 12175 Visionary Way, Fishers, IN, United States, 46038.
The company’s phone number is 317 286 6788.